ADORA2A and renal cell carcinoma: A2AR mRNA was measured in 31 pre-treatment RCC tumor biopsies and compared to other cancers (36 lung; 12 bladder; 5 colon; 8 prostate, 9 melanoma and 20 triple negative breast).